Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB known ✓ | P10828 | 4/20 | 0.48 |
| ▸ | ENPP2 | Q13822 | 5/20 | 0.71 |
| ▸ | SLC7A11 | Q9UPY5 | 3/20 | 0.56 |
| ▸ | APP | P05067 | 1/20 | 0.50 |
| ▸ | GLB1 | P16278 | 1/20 | 0.50 |
| ▸ | CHAT | P28329 | 1/20 | 0.50 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.50 |
| ▸ | CTRC | Q99895 | 1/20 | 0.50 |
| ▸ | SUMO2 | P61956 | 1/20 | 0.49 |
| ▸ | SUMO1 | P63165 | 1/20 | 0.49 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.49 |
| ▸ | SENP3 | Q9H4L4 | 1/20 | 0.49 |
| ▸ | SENP2 | Q9HC62 | 1/20 | 0.49 |
| ▸ | SENP1 | Q9P0U3 | 1/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.48 |
| ▸ | USP2 | O75604 | 2/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | HSPD1 | P10809 | 2/20 | 0.44 |
| ▸ | HSPE1 | P61604 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9793656 | 0.80 | SUMO2 (0.77) | ENPP2SLC7A11APPPHLPP2SUMO2 | |
| SCHEMBL16566668 | 0.79 | THRB (0.55) | ENPP2SLC7A11APPGLB1CHAT | |
| SCHEMBL29540025 | 0.79 | THRB (0.55) | ENPP2SLC7A11APPGLB1CHAT | |
| SCHEMBL1598800 | 0.79 | THRB (0.60) | ENPP2SLC7A11APPTHRBPTPN1 | |
| SCHEMBL29883166 | 0.79 | THRB (0.60) | ENPP2SLC7A11APPTHRBPTPN1 | |
| SCHEMBL29373132 | 0.79 | THRB (0.60) | ENPP2SLC7A11APPTHRBPTPN1 | |
| SCHEMBL26385 | 0.79 | THRB (0.60) | ENPP2SLC7A11APPTHRBPTPN1 | |
| SCHEMBL9406984 | 0.74 | THRB (0.53) | ENPP2SLC7A11APPGLB1CHAT | |
| SCHEMBL127635 | 0.71 | THRB (0.62) | ENPP2SLC7A11APPGLB1CHAT | |
| SCHEMBL30337585 | 0.71 | THRB (0.62) | ENPP2SLC7A11APPGLB1CHAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 580 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12569371-B2 | Sterilization of medical dressings with enhanced antimicrobial properties | HYDROFERA, LLC (US) | 2026-03-10 | — | — | US | claimed |
| US-12280160-B2 | Antimicrobial bandage | HYDROFERA, LLC (US) | 2025-04-22 | — | — | US | claimed |
| US-20230405178-A1 | ANTIMICROBIAL COMPRESSION WRAP | HYDROFERA LLC (US) | 2023-12-21 | — | — | US | claimed |
| US-11779678-B2 | Antimicrobial compression wrap | HYDROFERA, LLC (US) | 2023-10-10 | — | — | US | claimed |
| US-20230285197-A1 | STERILIZATION OF MEDICAL DRESSINGS WITH ENHANCED ANTIMICROBIAL PROPERTIES | HYDROFERA LLC (US) | 2023-09-14 | — | — | US | claimed |
| EP-3962369-A1 | ANTIMICROBIAL COMPRESSION WRAP | Hydrofera, LLC (US) | 2022-03-09 | — | — | EP | claimed |
| EP-3860663-A1 | STERILIZATION OF MEDICAL DRESSINGS WITH ENHANCED ANTIMICROBIAL PROPERTIES | Hydrofera, LLC (US) | 2021-08-11 | — | — | EP | claimed |
| EP-3630202-B1 | STAINING COMPOSITION WITH IMPROVED STAINING INTENSITY | D O R C DUTCH OPHTHALMIC RES CENTER INTERNATIONAL B V (NL) | 2021-05-26 | — | — | EP | claimed |
| WO-2020222885-A1 | ANTIMICROBIAL COMPRESSION WRAP | HYDROFERA, LLC (US) | 2020-11-05 | — | — | WO | claimed |
| US-20200345888-A1 | Antimicrobial compression wrap | HYDROFERA LLC | 2020-11-05 | — | — | US | claimed |
| WO-1999058160-A1 | THE USE OF A VITAL DYE FOR FACILITATING SURGICAL PROCEDURES FOR CATARACT EXTRACTION | MELLES GERRIT REINOLD JACOB (NL) | 1999-11-18 | — | — | WO | claimed |
| WO-1999058159-A1 | THE USE OF A VITAL DYE FOR FACILITATING SURGICAL PROCEDURES FOR VITREO-RETINAL SURGERY | MELLES GERRIT REINOLD JACOB (NL) | 1999-11-18 | — | — | WO | claimed |
| WO-1999013921-A2 | DISINFECTANT PLASTIC SPONGE MATERIAL | SHANBROM TECHNOLOGIES, LLC (US) | 1999-03-25 | — | — | WO | claimed |
| US-5858641-A | PASSING BLOOD THROUGH POLYMER FILTER PRIOR TO TRANSFUSIONS; USE OF DYES AND FILTER ENABLE LONG TERM STORAGE WITHOUT BACTERIAL, VIRAL OR PARASITE CONTAMINATION | SHANBROM TECHNOLOGIES, LLC (US) | 1999-01-12 | — | — | US | claimed |
| US-5811471-A | Disinfectant plastic sponge material | SHANBROM TECHNOLOGIES LLC (US) | 1998-09-22 | — | — | US | claimed |
| EP-0489102-A4 | PHARMACEUTICAL COMPOSITIONS CONTAINING AROMATIC POLYMERS AND THERAPEUTIC METHODS USING THE SAME | — | 1992-08-12 | — | — | EP | claimed |
| EP-0489102-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING AROMATIC POLYMERS AND THERAPEUTIC METHODS USING THE SAME | RORER INTERNATIONAL (HOLDINGS), INC. (US) | 1992-06-10 | — | — | EP | claimed |
| WO-1991003226-A2 | PHARMACEUTICAL COMPOSITIONS CONTAINING AROMATIC POLYMERS AND THERAPEUTIC METHODS USING THE SAME | RORER INTERNATIONAL (HOLDINGS), INC. (US) | 1991-03-21 | — | — | WO | claimed |
| EP-0354714-A2 | Pharmaceutical compositions containing polyaromatic compounds | HADASSAH MEDICAL ORGANIZATION (IL) | 1990-02-14 | — | — | EP | claimed |
| EP-0354818-A2 | Pharmaceutical compositions containing polyaromatic compounds as active ingredient and their use | HADASSAH MEDICAL ORGANIZATION (IL) | 1990-02-14 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12569371-B2 | Sterilization of medical dressings with enhanced antimicrobial properties | ACR, CD47, CD99 | THRB 787/4885ENPP2 3604/4885SLC7A11 3670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.